Current Report Filing (8-k)
March 18 2019 - 9:55AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event
Reported): March 18, 2019
OZOP SURGICAL CORP.
(Exact name of registrant as specified
in its charter
)
Nevada
|
000-55976
|
35-2540672
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
319 Clematis Street Suite 714 West Palm
Beach FL 33401
(Address of principal executive offices,
including zip code)
(866) 286-1055
(Registrant’s telephone number,
including area code)
Not applicable.
(Former name or former address, if changed
since last report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
☑
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
|
|
☐
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
|
Item 7.01.
|
Regulation FD Disclosure.
|
On March 18, 2019, Ozop Surgical Corp.
(the “Company”) issued a press release providing an update on the Company’s business operations, recent accomplishments
and anticipated milestones for year 2019. A copy of the press release is attached as Exhibit 99.1 hereto.
The
information contained in the press release attached hereto is being furnished and shall not be deemed filed for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability
of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such
filing.
Item 9.01
|
Financial Statements and
Exhibits.
|
(d) Exhibits
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press
release dated March 18, 2019 (furnished herewith).
|
*Filed herewith.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
|
OZOP SURGICAL CORP.
|
|
|
|
|
Date: March 18, 2019
|
By:
|
/s/Barry Hollander
|
|
|
Barry Hollander
|
|
|
Chief Financial Officer
|
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
From Apr 2023 to Apr 2024